Published in Cancer Weekly, January 22nd, 2008
"Sixty-one prostate cancer patients with a mean age (±SD) of 79 ±6 years who had received androgen deprivation therapy for 42 ±29 months were enrolled, and were treated with 2.5 mg of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.